<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------------------
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __)*
-------------------------------------------
Galileo Technology Ltd.
(NAME OF ISSUER)
Ordinary Shares, 0.01 New Israeli Shekels par value
(TITLE OF CLASS OF SECURITIES)
M47298100
(CUSIP NUMBER)
Matthew Gloss,
Marvell Semiconductor, Inc.
645 Almanor Ave.,
Sunnyvale, CA 94086
(408) 222-2500
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED
TO RECEIVE NOTICES AND COMMUNICATIONS)
October 16, 2000
(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
If the filing person has previously filed a statement on Schedule 13D to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-l(e), 240.13d-l(f) or 240.13d-l(g), check
the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original, and five
copies of the schedule, including all exhibits, should be filed with the
Commission. See Section 240.13d-7 for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes.)
(Continued on following pages)
(Page 1 of 11 Pages)
================================================================================
<PAGE> 2
------------------- ------------------
CUSIP No. M47298100 13D Page 2 of 11 Pages
------------------- ------------------
--------------------------------------------------------------------------------
(1) Name of Reporting Persons: Marvell Technology Group Ltd.
I.R.S. Identification Nos. of above persons (entities only):
77-0481679.
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
(3) SEC Use Only:
--------------------------------------------------------------------------------
(4) Source of Funds (See Instructions):
WC and/or OO
--------------------------------------------------------------------------------
(5) Check Box if Disclosure of Legal Proceedings is Required Pursuant:
to Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
(6) Citizenship or Place of Organization:
Bermuda
--------------------------------------------------------------------------------
NUMBER OF SHARES (7) Sole Voting
BENEFICIALLY OWNED Power 5,371,720*
BY EACH REPORTING -------------------------------------------------
PERSON WITH (8) Shared Voting
Power N/A
-------------------------------------------------
(9) Sole Dispositive
Power 5,371,720*
-------------------------------------------------
(10) Shared Dispositive
Power N/A
--------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person:
5,371,720*
--------------------------------------------------------------------------------
(12) Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares (See Instructions): [ ]
--------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11):
12.5%
--------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions):
CO
--------------------------------------------------------------------------------
* Or such other number of ordinary shares of the Issuer as equals 12.5% of the
outstanding Issuer ordinary shares immediately prior to the time of exercise.
<PAGE> 3
------------------- ------------------
CUSIP No. M47298100 13D Page 3 of 11 Pages
------------------- ------------------
ITEM 1. SECURITY AND ISSUER
This Statement on Schedule 13D (the "Statement") relates to
ordinary shares, par value 0.01 New Israeli Shekels per share
("Issuer Shares"), of Galileo Technology Ltd., an Israeli
corporation (the "Issuer").
The address of the Issuer's principal executive offices is Moshav
Manof, D.N. Misgaf 20184, Israel.
Responses to each item of this Statement are qualified in their
entirety by the provisions of the Exhibits hereto.
ITEM 2. IDENTITY AND BACKGROUND
Name of Reporting Person: Marvell Technology Group Ltd.
("Marvell")
Place of Organization: Bermuda
Principal Business: Design of integrated circuits for mixed-signal
and digital-signal processing for the high-speed, high-density,
digital data storage and broadband digital data networking
markets.
Address of Principal Business and Office: Address in Bermuda: at
Richmond House, 3rd Floor, #12 Par la Ville Road, Hamilton, HM DX
Bermuda. The address of Marvell's wholly-owned United States
subsidiary is Marvell Semiconductor, Inc., 645 Alamanor Avenue,
Sunnyvale, California 94086.
(d) and (e). During the last five years, Marvell has not (i) been
convicted in a criminal proceeding or (ii) been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, Federal or
State securities laws or finding any violation with respect to
such laws.
Attached hereto as Appendix A is information required by this Item
2 with respect to the executive officers and directors of Marvell.
All such individuals are U.S. citizens, except as otherwise
indicated on Appendix A.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The Issuer Shares reported on this Statement may be purchased by
Marvell upon the exercise of an option granted pursuant to the
provisions of a Stock Option Agreement entered into on October 16,
2000, between Marvell and the Issuer (the "Option Agreement"), a
copy of which is attached hereto as Exhibit 1 and is
<PAGE> 4
hereby expressly incorporated herein by reference. The Option
Agreement provides that Marvell may purchase 5,371,720 Issuer
Shares (or such other number of Issuer Shares as equals 12.5% of
the outstanding Issuer Shares immediately prior to the time of
exercise), at an exercise price of $55.10 per Issuer Share,
subject to adjustment under certain conditions (the "Option
Shares"). Although no final decision has been made by Marvell, in
the event of exercise of the option, Marvell expects to effect the
purchase of the Option Shares from a combination of its working
capital and/or the proceeds of debt issued by Marvell.
ITEM 4. PURPOSE OF TRANSACTION
On October 16, 2000, Marvell, the Issuer, and Toshack Acquisitions
Ltd., an Israeli corporation and wholly-owned subsidiary of
Marvell ("Acquisition"), entered into a Merger Agreement, a copy
of which is attached hereto as Exhibit 2 and is hereby expressly
incorporated herein by reference (the "Merger Agreement").
Pursuant to the Merger Agreement, Acquisition will be merged into
the Issuer (upon satisfaction or waiver of certain conditions),
the Issuer will be the surviving corporation and a wholly-owned
subsidiary of Marvell, and the shareholders of the Issuer will
receive 0.674 shares of Marvell common stock for each Issuer Share
(the "Merger"). Concurrently with the execution and delivery of
the Merger Agreement, and as an inducement for Marvell to enter
into the Merger Agreement, the Issuer and Marvell entered into the
Option Agreement.
The option becomes exercisable by Marvell on or after the time
immediately prior to the termination of the Merger Agreement
caused by the following events, as a result of which the Issuer
could become obligated to pay the fee specified in the Merger
Agreement:
(a) the Issuer's board receiving a Superior Proposal (as
defined in the Merger Agreement) and the Issuer paying the
liquidated damages set forth in the Merger Agreement to terminate
the agreement;
(b) the Issuer's board recommending a Superior Proposal to
the Issuer's shareholders;
(c) the Issuer's shareholders failing to approve the Merger
Agreement by the requisite vote at a meeting held for such
purpose;
(d) (i) any of the Issuer's representations or warranties
becoming untrue such that the condition that the Issuer's
representations and warranties be true and correct cannot be
satisfied by March 31, 2001, or a breach by the Issuer of any of
its representations or warranties set forth in the Merger
Agreement, each arising out of a willful breach of a
representation or warranty, or (ii) a material breach by the
Issuer of any of its covenants or agreements set forth in the
Merger Agreement arising out of an action by the Issuer or failure
to take an action by the Issuer which results in a breach of a
covenant by the Issuer if the breach is not cured within five
business days after notice; or
<PAGE> 5
(e) the Issuer's board withdrawing its approval or
recommendation of the Merger Agreement or ceasing to use its
reasonable best efforts to convene a shareholders' meeting to
approve the Merger Agreement.
The option granted pursuant to the Option Agreement will expire
upon the earlier of (x) the Effective Time (as defined in the
Merger Agreement), (y) the termination of the Merger Agreement in
accordance with its terms, other than as a result of the
occurrence of any event described in clauses (a) through (e) (each
a "Triggering Event"), and (z) the day that is the six (6) month
anniversary of the date on which the Merger Agreement is
terminated in accordance with its terms as a result of the
occurrence of a Triggering Event.
This summary of the Option Agreement and Merger Agreement does not
purport to be complete and is qualified in its entirety by
reference to the complete text of such agreements, attached hereto
as Exhibits 1 and 2.
The Option Agreement is intended to increase the likelihood that
the transactions contemplated by the Merger Agreement will be
consummated in accordance with its terms, and may discourage
persons from proposing a competing offer to acquire the Issuer or
its shares. The existence of the Option Agreement could
significantly increase the cost to a potential acquirer of
acquiring the Issuer, compared to such cost had the Issuer not
entered into the Option Agreement.
Upon consummation of the transactions contemplated by the Merger
Agreement, the Issuer Shares will cease to be quoted on the Nasdaq
National Market System, and they will become eligible for
termination of registration pursuant to Section 12(g) of the
Securities Exchange Act of 1934, as amended.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
The information contained in Item 4 is incorporated herein by this
reference.
(a) Marvell has an option to purchase 5,371,720 Issuer Shares
(or such other number of Issuer Shares as equals 12.5% of
the outstanding Issuer Shares immediately prior to the time
of exercise).
Except as set forth in this Statement and Appendix A, to
the knowledge of Marvell, none of the persons listed in
Appendix A beneficially owns any of the Issuer Shares.
(b) Assuming exercise of the option, subject to the Issuer's
right, under certain conditions, to purchase the Option
Shares, Marvell will have sole dispositive and voting power
over all of the shares it elects to purchase under the
Option Agreement.
(c) There have been no transactions in the Issuer Shares by
Marvell during the past 60 days. Except as set forth in
this Statement and Appendix A, to the
<PAGE> 6
knowledge of Marvell, none of the persons listed in
Appendix A has effected any transactions in the Issuer
Shares in the past 60 days.
(d) Subject to the Issuer's right, under certain conditions, to
purchase the Option Shares, and subject to the limitation
on Marvell's Total Profit (as defined in the Option
Agreement), no other person, including the persons listed
in Appendix A, has the right to receive or the power to
direct the receipt of dividends from, or the proceeds of
sale of, securities covered by this Statement.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER
Pursuant to the Option Agreement, (i) Marvell has certain
registration rights with respect to shares purchased upon exercise
of the option pursuant to the Option Agreement, (ii) Marvell has
the option to elect a cash payment, under specified conditions,
from the Issuer in lieu of exercising its option, and (iii) the
Issuer has the right, under certain conditions, to purchase from
Marvell the Option Shares acquired upon exercise of the option.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1. Stock Option Agreement, dated as of October 16,
2000, by and between Marvell Technology Group Ltd.
and Galileo Technology Ltd., incorporated by
reference to Marvell's filing on October 20, 2000
pursuant to Rule 425 promulgated under the
Securities Act of 1933, as amended.
Exhibit 2. Agreement of Merger, dated as of October 16,
2000, by and among Marvell Technology Group Ltd.,
Galileo Technology Ltd., and Toshack Acquisitions
Ltd., incorporated by reference to Marvell's filing
on October 20, 2000 pursuant to Rule 425
promulgated under the Securities Act of 1933, as
amended.
<PAGE> 7
------------------- ------------------
CUSIP No. M47298100 13D Page 7 of 11 Pages
------------------- ------------------
SIGNATURE
After reasonable inquiry and to the best of his knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated as of October 24, 2000
MARVELL TECHNOLOGY GROUP LTD.
By: /s/ Weili Dai
---------------------------------
Name: Weili Dai
Title: Executive Vice President
<PAGE> 8
------------------- ------------------
CUSIP No. M47298100 13D Page 8 of 11 Pages
------------------- ------------------
Appendix A
DIRECTORS AND EXECUTIVE OFFICERS OF MARVELL
The following is a list of all directors and executive officers of Marvell and
certain other information with respect to each such person. All such persons,
with the exception of Herbert Chang, are United States citizens. To the
knowledge of Marvell, no such person, during the last five years, has (i) been
convicted in a criminal proceeding or (ii) been a party to a civil proceeding of
a judicial or administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, Federal
or State securities laws or finding any violation with respect to such laws.
Name: Dr. Sehat Sutardja
Mr. Sehat Sutardja is President, Chief Executive Officer and
Co-Chairman of the Board of Marvell. In addition, he is President,
Chief Executive Officer and a director of Marvell Semiconductor,
Inc. Mr. Sutardja's business address is Marvell Semiconductor,
Inc., 645 Almanor Ave., Sunnyvale, CA 94086.
Name: Weili Dai
Ms. Dai is Executive Vice President and a director of Marvell. In
addition, she is Executive Vice President and a director for
Marvell Semiconductor, Inc. Ms. Dai's business address is Marvell
Semiconductor, Inc., 645 Almanor Ave., Sunnyvale, CA 94086.
Name: Dr. Pantas Sutardja
Mr. Pantas is Vice President and a director of Marvell. In
addition, he is Chief Technology Officer and a director of Marvell
Semiconductor, Inc. Mr. Sutardja's business address is Marvell
Semiconductor, Inc., 645 Almanor Ave., Sunnyvale, CA 94086.
Name: George Hervey
Mr. Hervey is Vice President of Finance and Chief Financial
Officer of Marvell. Mr. Hervey's business address is Marvell
Semiconductor, Inc., 645 Almanor Ave., Sunnyvale, CA 94086. To the
knowledge of Marvell, a description of all transactions effected
by Mr. Hervey in the past 60 days and his beneficial ownership of
shares of the Issuer are set forth on Attachment 1 to this
Appendix A.
Name: Diosdado P. Banatao
<PAGE> 9
Mr. Banatao is Co-Chairman of the Board of Marvell and a partner
in Mayfield Fund, a venture capital fund. Mr. Banatao's business
address is 635 Waverley Street, Palo Alto, California 94301.
Name: Herbert Chang
Mr. Chang is a director of Marvell and President of InveStar
Capital, Inc., a technology venture capital management firm based
in Taiwan. Mr. Chang's business address is 3600 Pruneridge Avenue,
Santa Clara, California 95051. Mr. Chang is a citizen of Taiwan
(ROC).
Name: John M. Cioffi
Mr. Cioffi is a director of Marvell and a professor of Electrical
Engineering at Stanford University. Mr. Cioffi's business address
is 1540 Oak Space Creek #304, Palo Alto, California 94304.
Name: Paul R. Gray
Mr. Gray is a director of Marvell and Dean of the College of
Engineering at the University of California at Berkeley and
Executive Vice Chancellor and Provost. Mr. Gray's residential
address is 63 La Cruesta, Orinda, California 94536.
Name: Ron Verdoorn
Mr. Verdoorn is a director of Marvell and Executive Vice President
of Manufacturing for Affymetrix, Inc., a company specializing in
the development of technology for acquiring and managing complex
genetic information for use in biomedical research, genomics and
clinical diagnostics. Mr. Verdoorn's residential address is 18850
Bella Vina, Saratoga, California 95070.
<PAGE> 10
------------------- -------------------
CUSIP No. M47298100 13D Page 10 of 11 Pages
------------------- -------------------
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT NO. DESCRIPTION
----------- -----------
<S> <C>
1 Stock Option Agreement, dated as of October 16, 2000,
by and between Marvell Technology Group Ltd. and
Galileo Technology Ltd., incorporated by reference to
Marvell's filing on October 20, 2000 pursuant to Rule
425 promulgated under the Securities Act of 1933, as
amended.
2 Agreement of Merger, dated as of October 16, 2000, by
and among Marvell Technology Group Ltd., Galileo
Technology Ltd., and Toshack Acquisitions Ltd.,
incorporated by reference to Marvell's filing on
October 20, 2000 pursuant to Rule 425 promulgated
under the Securities Act of 1933, as
amended.
</TABLE>
<PAGE> 11
------------------- -------------------
CUSIP No. M47298100 13D Page 11 of 11 Pages
------------------- -------------------
Attachment 1
to
Appendix A
Set forth below are exercises of options of the Issuer effected by Mr. George
Hervey in the past 60 days. The options were granted to Mr. Hervey during the
period Mr. Hervey was an officer of the Issuer from March 1997 to April 2000 and
would have terminated 6 months after Mr. Hervey left his employment at the
Issuer had they not been exercised. The shares of the Issuer purchased upon
exercise of the options were sold on the date of exercise in broker transactions
at market prices.
<TABLE>
<CAPTION>
DATE OF SALE NO. SHARES EXERCISE PRICE SALE PRICE
------------ ---------- -------------- ----------
<S> <C> <C> <C>
8/28/00 400 $16.6875 $27.2500
8/28/00 3,498 $16.6875 $26.8750
8/28/00 4,000 $ 5.6250 $26.8750
9/7/00 3,000 $ 5.6250 $28.3125
9/7/00 2,000 $16.6875 $28.3125
9/11/00 24,330 $ 3.5000 $27.0000
9/13/00 3,500 $ 3.5000 $26.0000
9/13/00 6,000 $16.6875 $26.0000
9/13/00 18,670 $16.6875 $25.6875
9/18/00 12,000 $ 5.6250 $26.4375
-------
Totals 77,398
=======
</TABLE>
Mr. Hervey no longer holds any options to purchase shares of the Issuer.
